<DOC>
	<DOCNO>NCT00319254</DOCNO>
	<brief_summary>The purpose study determine SKI-606 ( Bosutinib ) effective treatment advance metastatic breast cancer . Patients must current Stage IIIB , IIIC IV breast cancer progress 1 3 prior chemotherapy regimen .</brief_summary>
	<brief_title>Study Evaluating SKI-606 ( Bosutinib ) In Subjects With Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Stage IIIB , IIIC IV breast cancer curable available therapy . Patients must progress 1 3 prior chemotherapy regimen . Life expectancy least 16 week . Ability swallow whole capsule . Use requirement bisphosphonates within 8 week prior screen . Any cancer within 5 year screen , except basal cell carcinoma cervical carcinoma situ Uncontrolled cardiac disease include congestive heart failure , angina , heart attack , etc . Recent ongoing significant gastrointestinal disorder</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Advanced Breast Cancer</keyword>
</DOC>